Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 28, 2019; 25(32): 4580-4597
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4580
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4580
Table 1 Prevalence rates throughout the world
| Geographic area | Prevalence (%) | Ref. |
| HDV ab | HDV RNA | ||
| Africa | ||
| Gabon | 63-70.6 | X | [137] |
| Nigeria | 4.9 | 9 | [138] |
| Sub-Saharan | 1.3-50 | 21.4-100 | [139] |
| Tunisia | 2 | 33.3 | [140] |
| Asia | ||
| Japan | 21.1 | X | [141] |
| Mongolia | 74.4 | 97.9 | [9] |
| 90.7 | 91.4 | [142] | |
| Pacific | ||
| Kiribati | X | 37 | [143] |
| North America | ||
| United States | 42 | X | [144] |
| South America | ||
| Brazil | 1.8 | X | [145] |
| 34.4 | X | [146] | |
| Europe | ||
| Belgium | 3.7-5.5 | X | [147] |
| Greece | 4.2 | X | [148] |
| Italy | 67 | 93 | [149] |
| 23.4 | X | [150] | |
| London | 4.5 | 20.2 | [151] |
| Romania | 23.1 | 71.0 | [8] |
| Spain | 4 | X | [152] |
| 8.2 | X | [17] |
- Citation: Gilman C, Heller T, Koh C. Chronic hepatitis delta: A state-of-the-art review and new therapies. World J Gastroenterol 2019; 25(32): 4580-4597
- URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4580.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4580
